Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
First moderate complexity molecular test for sexually transmitted infections on fully automated, high throughput platform Broad set of urogenital sample claims ensure greatest flexibility for patient access New test for most common sexually transmitt... Diagnostics, FDA Roche Group, cobas, cobas CT/NG, chlamydia, gonorrhoeae
This study assessed chlamydia and gonorrhea rates by unit of country assignment and evaluated the demographic profile of affected personnel during deployment. Chlamydia and gonorrhea cases among active duty personnel were identified from laboratory results and ambulatory encounter records in the Military Health System from fiscal years October 2006 through September 2015; these were linked to personnel and deployment records to ascertain demographic characteristics, unit of country assignment, and if the case was captured during a period of deployment. Case rates were higher for chlamydia (1,321.7 per 100,000) than gonorrh...
Conclusions Chlamydia and gonorrhea testing levels are low among Chinese MSM. Integrating chlamydia and gonorrhea test promotion strategies into HIV prevention programs that engage MSM communities may help bridge the gap.
Conclusions: Integrating PrEP referrals into STD PS is an effective population-based strategy to link MSM at high HIV risk to PrEP.
Chronic endometritis (CE) is an inflammation of the endometrial mucosa caused by acute or chronic subclinical infection of the uterine cavity. Most commonly, CE is provoked by the microbial pathogens Enterococcus faecalis, Enterobacteriaceae, Streptococcus spp., Staphylococcus spp., Gardnerella vaginalis, and Mycoplasma spp., as well as genital pathogens associated with sexually transmitted infections (Ureaplasma urealyticum, Chlamydia trachomatis, and Neisseria gonorrhoeae). These bacterial pathogens underlie this invisible pathology that is still within the inflammation cloud, is supported by the efficacy of antibiotic t...
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) are among the most common sexually transmitted infections in the United States and have the potential for serious sequelae. Expedited partner therapy (EPT) is an intervention supported by the Centers for Disease Control and proven to decrease recurrent or persistent sexually transmitted infections, however there is limited evidence of its acceptance and compliance in the adolescent population. Our study aimed to measure acceptance and uptake rates of EPT among women infected with GC and/or CT at an urban health clinic, and identify patient factors that may influence...
CONCLUSION: Among African women at high HIV-1 risk, STIs were common. Risk of cervical infections did not differ across contraceptive methods. Significantly higher rates of T. vaginalis were observed among progestin-based methods compared to copper IUD users. Overall, these findings call for more intensive routine screening for STIs, and they support current World Health Organization guidance that women should have a wide range of contraceptive options. PMID: 30816632 [PubMed - in process]
Conclusions Provider-entered EHR data are increasingly being used in research studies; thus, it is important to ensure its accuracy and reliability before study implementation.
(MedPage Today) -- Research on gonorrhea finds similar risks for ectopic pregnancy, tubal infertility as chlamydia
Conclusions Homeless and unstably housed PLWH had 34% lower odds of GC/CT screening at a PCV, demonstrating a disparity in routine care provision, but similar time in coverage. More research is needed to effectively increase GC/CT screening among HUH-PLWH.
Conclusions Presumptive treatment for CT/GC was commonly used in this clinic population. It improved treatment coverage and reduced time to treatment, though some uninfected persons were treated. The impact of presumptive treatment on partner notification and treatment requires further study.